BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9111293)

  • 1. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
    Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
    J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense.
    Xiao W; Li G; Player MR; Maitra RK; Waller CF; Silverman RH; Torrence PF
    J Med Chem; 1998 Apr; 41(9):1531-9. PubMed ID: 9554886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.
    Player MR; Maitra RK; Silverman RH; Torrence PF
    Antivir Chem Chemother; 1998 May; 9(3):225-31. PubMed ID: 9875401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling gene expression with 2-5A antisense.
    Leaman DW; Cramer H
    Methods; 1999 Jul; 18(3):252-65. PubMed ID: 10454983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells.
    Kushner DM; Paranjape JM; Bandyopadhyay B; Cramer H; Leaman DW; Kennedy AW; Silverman RH; Cowell JK
    Gynecol Oncol; 2000 Feb; 76(2):183-92. PubMed ID: 10637068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.
    Maitra RK; Li G; Xiao W; Dong B; Torrence PF; Silverman RH
    J Biol Chem; 1995 Jun; 270(25):15071-5. PubMed ID: 7797490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides.
    Silverman RH; Dong B; Maitra RK; Player MR; Torrence PF
    Methods Enzymol; 2000; 313():522-33. PubMed ID: 10595377
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of antisense oligonucleotides carrying modified 2-5A molecules at their 5'-termini and their properties.
    Ueno Y; Kato Y; Okatani S; Ishida N; Nakanishi M; Kitade Y
    Bioconjug Chem; 2003; 14(3):690-6. PubMed ID: 12757397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides.
    Cramer H; Player MR; Torrence PF
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1049-54. PubMed ID: 10230638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
    Barnard DL; Sidwell RW; Xiao W; Player MR; Adah SA; Torrence PF
    Antiviral Res; 1999 Apr; 41(3):119-34. PubMed ID: 10320045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.
    Maran A; Waller CF; Paranjape JM; Li G; Xiao W; Zhang K; Kalaycio ME; Maitra RK; Lichtin AE; Brugger W; Torrence PF; Silverman RH
    Blood; 1998 Dec; 92(11):4336-43. PubMed ID: 9834240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L.
    Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF
    Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
    Kondo Y; Kondo S
    Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
    Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of chimeric 2-5A-DNA oligonucleotides.
    Player MR; Torrence PF
    Curr Protoc Nucleic Acid Chem; 2001 May; Chapter 4():Unit 4.4. PubMed ID: 18428851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
    Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the antisense oligonucleotides carrying the modified 2-5A molecules at their 5'-termini and their properties.
    Ueno Y; Kato Y; Okatani S; Kitade Y
    Nucleic Acids Res Suppl; 2002; (2):45-6. PubMed ID: 12903097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras.
    Maran A; Maitra RK; Kumar A; Dong B; Xiao W; Li G; Williams BR; Torrence PF; Silverman RH
    Science; 1994 Aug; 265(5173):789-92. PubMed ID: 7914032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
    Lima WF; Crooke ST
    Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.